product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Vitamin D3 Receptor (D2K6W) Rabbit mAb
catalog :
12550
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D2K6W
reactivity :
human
application :
western blot
citations: 2
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig 3
Gari H, Gearheart C, Fosmire S, Degala G, Fan Z, Torkko K, et al. Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers. Oncotarget. 2016;7:15757-71 pubmed publisher
Susa T, Iizuka M, Okinaga H, Tamamori Adachi M, Okazaki T. Without 1?-hydroxylation, the gene expression profile of 25(OH)D3 treatment overlaps deeply with that of 1,25(OH)2D3 in prostate cancer cells. Sci Rep. 2018;8:9024 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.